Abnormal Involuntary Movement Scale (AIMS)
0(min disability) - 42(max)
The Abnormal Involuntary Movement Scale (AIMS) is a brief clinician‑rated tool used to detect and quantify tardive dyskinesia.
Indications for Use
Used to detect, rate, and monitor tardive dyskinesia and other antipsychotic‑related abnormal movements, especially for baseline assessment and treatment response tracking. Provides a standardized severity score and is the primary outcome measure in TD clinical trials 1. Helps guide decisions on VMAT2‑inhibitor therapy and differentiate TD from other extrapyramidal symptoms 2.
Insights & Cautions
Detects and tracks tardive dyskinesia but is not a diagnostic tool, and scores can vary with rater skill and patient cooperation. Best used serially to monitor change; single scores have limited clinical meaning. Missing subtle oro‑facial movements and underestimating severity are common. Inter‑rater reliability is moderate (systematic review; 24 studies 1 [Level II evidence]). Should complement—not replace—clinical judgment.